Annual Shareholders Equity
$18.32 M
-$42.78 M-70.02%
December 31, 2023
Summary
- As of February 8, 2025, VIRX annual stockholders equity is $18.32 million, with the most recent change of -$42.78 million (-70.02%) on December 31, 2023.
- During the last 3 years, VIRX annual shareholders equity has risen by +$64.52 million (+139.65%).
- VIRX annual shareholders equity is now -80.59% below its all-time high of $94.37 million, reached on December 31, 2021.
Performance
VIRX Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Shareholders Equity
-$6.62 M
-$9.29 M-347.73%
September 30, 2024
Summary
- As of February 8, 2025, VIRX quarterly stockholders equity is -$6.62 million, with the most recent change of -$9.29 million (-347.73%) on September 30, 2024.
- Over the past year, VIRX quarterly shareholders equity has dropped by -$24.94 million (-136.12%).
- VIRX quarterly shareholders equity is now -105.30% below its all-time high of $124.74 million, reached on March 31, 2021.
Performance
VIRX Quarterly Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Shareholders Equity Formula
Shareholders Equity = Total Assets − Total Liabilities
VIRX Shareholders Equity Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -70.0% | -136.1% |
| 3 y3 years | +139.7% | -136.1% |
| 5 y5 years | +139.7% | -136.1% |
VIRX Shareholders Equity Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -80.6% | at low | -107.0% | at low |
| 5 y | 5-year | -80.6% | +139.7% | -105.3% | +85.7% |
| alltime | all time | -80.6% | +139.7% | -105.3% | +85.7% |
Viracta Therapeutics Shareholders Equity History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | -$6.62 M(-347.7%) |
| Jun 2024 | - | $2.67 M(-75.9%) |
| Mar 2024 | - | $11.08 M(-39.5%) |
| Dec 2023 | $18.32 M(-70.0%) | $18.32 M(-39.0%) |
| Sep 2023 | - | $30.01 M(-26.4%) |
| Jun 2023 | - | $40.78 M(-20.2%) |
| Mar 2023 | - | $51.11 M(-16.3%) |
| Dec 2022 | $61.10 M | $61.10 M(-9.9%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2022 | - | $67.81 M(-11.9%) |
| Jun 2022 | - | $77.00 M(-10.0%) |
| Mar 2022 | - | $85.61 M(-9.3%) |
| Dec 2021 | $94.37 M(-304.3%) | $94.37 M(-9.2%) |
| Sep 2021 | - | $103.97 M(-11.2%) |
| Jun 2021 | - | $117.10 M(-6.1%) |
| Mar 2021 | - | $124.74 M(-370.0%) |
| Dec 2020 | -$46.20 M | -$46.20 M |
FAQ
- What is Viracta Therapeutics annual stockholders equity?
- What is the all time high annual shareholders equity for Viracta Therapeutics?
- What is Viracta Therapeutics annual shareholders equity year-on-year change?
- What is Viracta Therapeutics quarterly stockholders equity?
- What is the all time high quarterly shareholders equity for Viracta Therapeutics?
- What is Viracta Therapeutics quarterly shareholders equity year-on-year change?
What is Viracta Therapeutics annual stockholders equity?
The current annual shareholders equity of VIRX is $18.32 M
What is the all time high annual shareholders equity for Viracta Therapeutics?
Viracta Therapeutics all-time high annual stockholders equity is $94.37 M
What is Viracta Therapeutics annual shareholders equity year-on-year change?
Over the past year, VIRX annual stockholders equity has changed by -$42.78 M (-70.02%)
What is Viracta Therapeutics quarterly stockholders equity?
The current quarterly shareholders equity of VIRX is -$6.62 M
What is the all time high quarterly shareholders equity for Viracta Therapeutics?
Viracta Therapeutics all-time high quarterly stockholders equity is $124.74 M
What is Viracta Therapeutics quarterly shareholders equity year-on-year change?
Over the past year, VIRX quarterly stockholders equity has changed by -$24.94 M (-136.12%)